Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 3060159)

1.

Veno-occlusive disease in children after intensive chemo- and radiotherapy and repeated halothane anesthesias. A report of 2 cases.

Gentet JC, Bernard JL, Aimard L, Alfonsi SM, Raybaud C.

Acta Oncol. 1988;27(5):579-81.

PMID:
3060159
2.

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB.

Biol Blood Marrow Transplant. 1999;5(5):306-15.

PMID:
10534061
4.

Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.

Rosenthal J, Sender L, Secola R, Killen R, Millerick M, Murphy L, Cairo MS.

Bone Marrow Transplant. 1996 Jul;18(1):185-91.

PMID:
8832013
5.

Is veno-occlusive disease incidence influenced by the total-body irradiation technique?

Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.

Strahlenther Onkol. 1995 Dec;171(12):694-7.

PMID:
8545791
6.

Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.

McCowage GB, Vowels MR, Shaw PJ, Lockwood L, Mameghan H.

J Clin Oncol. 1995 Nov;13(11):2789-95.

PMID:
7595740
7.

Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.

Bonetti F, Zecca M, Pession A, Messina C, Montagna D, Lanino E, Fagioli F, Santoro N, Prete A, Cesaro S, Rondelli R, Giorgiani G, De Stefano P, Locatelli F.

J Clin Oncol. 1999 Dec;17(12):3729-35.

PMID:
10577844
8.

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA.

Ann Intern Med. 1993 Feb 15;118(4):255-67.

PMID:
8420443
9.

Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome.

Brugieres L, Hartmann O, Benhamou E, Zafrani ES, Caillaud JM, Patte C, Kalifa C, Flamant F, Lemerle J.

Bone Marrow Transplant. 1988 Jan;3(1):53-8.

PMID:
3048471
10.

Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.

Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ; Spanish Myeloma Group/PETHEMA.

Biol Blood Marrow Transplant. 2007 Dec;13(12):1448-54.

11.

[Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].

Dini G, Garaventa A, Lanino E, Perin GP, Scarpati D, Viscoli C, Franchini E, Corvò R, Dallorso S, Cinollo G, et al.

Pediatr Med Chir. 1987 Jan-Feb;9(1):1-7. Italian.

PMID:
3306621
12.

Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.

Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):28-39.

PMID:
12694821
13.

Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.

Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N.

Bone Marrow Transplant. 1998 Dec;22(12):1191-7.

14.

[Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].

Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.

Sangre (Barc). 1996 Apr;41(2):101-8. Spanish.

PMID:
9045349
15.

Toxicities of total-body irradiation for pediatric bone marrow transplantation.

Chou RH, Wong GB, Kramer JH, Wara DW, Matthay KK, Crittenden MR, Swift PS, Cowan MJ, Wara WM.

Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):843-51.

PMID:
8598361
16.

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.

Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP.

Br J Haematol. 1998 Aug;102(3):656-65.

PMID:
9722290
17.

Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation.

Norris S, Crosbie O, McEntee G, Traynor O, Nolan N, McCann S, Hegarty J.

Transplantation. 1997 May 27;63(10):1521-4.

PMID:
9175821
18.

Hepatic veno-occlusive disease after bone marrow transplant.

Carreras E, Grañena A, Rozman C.

Blood Rev. 1993 Mar;7(1):43-51. Review.

PMID:
8467232
19.

A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.

Kamani N, August CS, Bunin N, Leahey A, Bayever E, Goldwein J, Zusman J, Evans AE, Angio GD.

Bone Marrow Transplant. 1996 Jun;17(6):911-6.

PMID:
8807093
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk